Identifying Genetic Targets in Gynecological Tumors

Recruiting now

Conditions studied: Ovarian Cancer

In brief

This observational study aims to identfy genetic targets involved in the pathogenesis of gynecological tumors, with a focus on high-grade serous ovarian carcinoma. Using a triple approach - in silico, ex vivo and in vitro - the study will investigate the role of gonadotropins and their related signaling pathways in the epithelial ovarian cancers. Gene and protein expression levels will be evaluated through transcriptomic analysis, immunohistochemistry and functional assays on tumor cell lines. The goal is to uncover potential diagnostic or therapeutic targets in gynecological malignancies.

Key facts

Study ID

NCT07169396

Run by

Azienda USL Reggio Emilia - IRCCS

People needed

180

Starts

2021-11-17

Expected to finish

2027-11-01

Last updated by the study team

2026-07-24

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Adult women ≥18 years old
• Histologically confirmed diagnosis of epithelial ovarian cancer (including high- grade serous, endometrioid, mucinous, clear cell, or mesonephric-like histotypes)
• Signed informed consent (for prospective cases) or ethically approved waiver (for retrospective samples)

You may not qualify if…

• Refusal to sign informed consent
• Diagnosis of low-grade or non-epithelial ovarian tumors
• Patients whose clinical or pathological data are unavailable or insufficient for study inclusion

Where it is running

• Azienda USL IRCCS di Reggio Emilia — Reggio Emilia, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.